← Back
$KYMR All transactions

Kymera Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$733K

Shares

24,727

Price

$30

Filed

Mar 25

Insider

Name

Chadwick Jeremy G

Title

Chief Operating Officer

CIK

0001388406

Roles

Officer

Transaction Details

Transaction Date

2026-03-25

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

85,929

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.96 to $76,94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.95 to $77.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.98 to $78.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.01 to $80.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $80.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | Twenty-five percent (25%) of the shares underlying this stock option vested on May 22, 2024 and the remaining shares shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Filing Info

Accession No.

0001193125-26-124367

Form Type

4

Issuer CIK

0001815442

Chadwick Jeremy G's History

Date Ticker Type Value
2026-04-15 KYMR M $57K
2026-04-15 KYMR $117K
2026-04-15 KYMR M $0
2026-04-14 KYMR M $135K
2026-04-14 KYMR M $34K
2026-04-14 KYMR $473K
2026-04-14 KYMR M $0
2026-04-14 KYMR M $0
2026-04-01 KYMR M $434K
2026-04-01 KYMR $1.2M

Other Insiders at KYMR (90d)

Insider Bought Sold Last
Chadwick Jeremy G
Chief Operating Officer
$11.5M 2026-04-15
Booth Bruce $855K 2026-04-15
Ridloff Elena $1.0M 2026-04-01
Goodman Noah
Chief Business Officer
$1.0M 2026-04-14